Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Patient Information Leaflet last updated on the eMC: 30/11/2011
PIL PEDIACEL

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 30/11/2011 and displayed until Current
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to dosage and administration
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 07/05/2010 and displayed until 30/11/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/08/2009 and displayed until 07/05/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/05/2009 and displayed until 14/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 04/06/2008 and displayed until 15/05/2009
Reasons for adding or updating:
  • Change to appearance of the medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
Updated on 20/04/2006 and displayed until 04/06/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC